GB2066266A - An enzymatically obtained oligomer of L-amino acid, a process for its preparation and its uses - Google Patents

An enzymatically obtained oligomer of L-amino acid, a process for its preparation and its uses Download PDF

Info

Publication number
GB2066266A
GB2066266A GB8041099A GB8041099A GB2066266A GB 2066266 A GB2066266 A GB 2066266A GB 8041099 A GB8041099 A GB 8041099A GB 8041099 A GB8041099 A GB 8041099A GB 2066266 A GB2066266 A GB 2066266A
Authority
GB
United Kingdom
Prior art keywords
methionine
oligomer
amino acid
acid
residues
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB8041099A
Other versions
GB2066266B (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Societe des Produits Nestle SA
Nestle SA
Original Assignee
Societe des Produits Nestle SA
Nestle SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe des Produits Nestle SA, Nestle SA filed Critical Societe des Produits Nestle SA
Publication of GB2066266A publication Critical patent/GB2066266A/en
Application granted granted Critical
Publication of GB2066266B publication Critical patent/GB2066266B/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Description

1 - 5 GB2066266A 1
SPECIFICATION
An enzymatically obtained oligomer of L-amino acid, a process for its preparation and its uses This invention relates to a enzymatically obtained oligomer of L-amino acid, a process for its preparation and its uses.
More particularly the invention relates to an enzymatically obtained oligomer of L-amino acid containing residues of L-methionine and consisting essentially of oligomers having a chain length of from 5 to 10 residues with an average length of 8. The invention also relates to a process for the preparation of this oligomer and to its use either as an L-methionine substitute in the fortification of food diets or as an intermediate product in the preparation of L- methionine from DL-methionine.
Certain food ingredients which are naturally poor in sulphur-containing amino acids, such as soya proteins, leaf proteins and microbial proteins,may be or have to be fortified with methionine, particularly for dietetic or infantile applications. DL- methionine, which is produced by chemical synthesis on a scale of 100,000 t per year, is consumed above all by cattle and poultry because it cannot be reliably used in foods for human consumption. 20 So far as human beings are concerned, only L-methionine is being considered for use at the 20 present time. L-methionine is produced from DL-methionine on a scale of from 50 to 100 t per year by enzymatic separation of the two enantiomers. Because of this, L-methionine is approximately 10 times more expensive than IDL-methionine. Oligomers of methionine, principally the dimer, have been chemcially synthesised:
-by the reaction of N-protected methionine. such as N-carbobenzoxy methionine, with the ethyl ester of methionine in the presence of a coupling agent, such as cyclohexyl carbodiimide, and cleavage of the protective group; -from N-carboxy anhydride or Leuch's anhydrides in the presence of free amino acid, in aqueous medium, in the absence of heat and at a pH-value of 10 (Hirschmann method).
These methods are expensive and use unstable products or coupling reactants of which the 30 purity has to be guaranteed.
In addition, poly-L-methionines of high molecular weight have been obtained from N-carboxy anhydrides by polymerisation in anhydrous medium. However, this method also involves the use of Leuch's anhydrides which are difficult to handle.
Accordingly, these methods have never been used in the preparation of food additives on account of their high cost and the guarantee of purity required in the interests of food hygiene.
It is therefore easy to appreciate the advantage there would be in having either a safe substitute for L-methionine, releasing it under ingestion conditions, or Lmethionine available at a fairly moderate price.
The present invention meets precisely these two objectives. It provides an oligomer of L-amino 40 acid containing residues of L-methionine consisting essentially of oligomers having a chain length of from 5 to 10 residues with an average length of 8 and having an L-methionine content amounting from 60 to 90% by weight. In one embodiment, the oligomer is a homo-oligomer consisting of residues of L-methionine. An aligomer such as this is insoluble in water and aqueous buffers and soluble in dimethyl sulphoxide (DMSO); its total nitrogen content amounts 45 to from 9.5 to 10.5% and its specific rotation [a]25 lies between - 12 and - 14' (DMSO).
D The expression---insolublein water--- is understood to mean that, in vitro, the oligo-L methionine does not dissolve significantly in water. This does not in any way pre-judge (rather on the contrary) its solubility in vivo in aqueous media and biological fluids.
In one variant, the oligomer is a hetero-oligomer, i.e. in addition to the methionine residues, it 50 contains residues of other amino acids. An oligomer such as this is soluble for example in aqueous media providing residues of polar amino acids, such as glutamic acid or aspartic acid, are introduced therein.
Alternatively, it may be more digestible with respect to pancreatic enzymes than the homo- oligomer of L-methionine, for example through the introduction of residues of aromatic amino 55 acids, such as tryptopha phenylalanine or tyrosine, through the creation of additional cleavage sites for the pancreatic proteases, which facilitates enzymatic hydrolysis.
In addition, the oligomer releases the L-methionine under acid pHconditions such as are encountered in the stomach for example. It will therefore be appreciated that, through the oligo L-methionine, it is possible to obtain L-methionine from DL-methionine, as described hereinafter 60 in the disclosure of the invention. The process as a whole, although involving enzymatic intervention, is better suited to the preparation of L-methionine than the enzymatic resolution process mentioned above.
The present invention also provides a process for the preparation of the L-amino acid oligomer, which comprises reacting an ester of methionine and, optionally, of one or more other 65 2 GB2066266A 2 amino acids with a thiol-protease;in an aqueous medium having a pH-value of from 5 to 7 at a temperature where the thiol-protease is active, and thereafter isolating the L-amino acid oligomer formed from the reaction medium.
It is pointed out that the starting methionine may be either L-methionine or DL-methionine. In the latter case, the reaction medium contains unreacted D-methionine in the form of its ester. 5 Preparation of the methionine ester, preferably the methyl or ethyl ester, is a simple, uncomplicated preliminary step. The operation involved may be carried out very easily by reacting methionine with the corresponding alcohol in the presence of thionyl chloride (SOC12).
In the case of a hetero-oligomer, it is sufficient to add the required quatity of amino acid(s) in the form of its/their ester(s), preferably the methyl or ethyl ester(s), prepared as described above to the reaction mixture consisting of the methionine ester and the thiol- protease. It is possible to use for example the ethyl esters of DL or L-tryptophan, of DL-tyrosine, a, y-diethyl glutamate.
Where a DL-amino acid is used to start with, an L-residue will be obtained as indicated above for methionine.
The thiol-protease used is preferably papain, ficin, or bromelin which are inexpensive and abundant enzymes. in their case, the reaction is carried out at a temperature in the range from 30'1C to 50C and preferably at a temperature of the order of 37'C.
The aqueous reaction medium used may be quite simply water. In that case, the pH-value should be monitored to ensure 'chat it remains within the limits indicated above, preferably constant. As the enzymatic reaction progresses, an alkaline agent, such as 2N sodium hydroxide 20 for example, will be added. Another possibility is to use a buffer solution as the aqueous medium, for example a buffer solution of sodium salts of carboxylic acids, Na citrate, Na succinate, Na acetate, etc.
The pH-value of the aqueous medium is the determining factor for the enzymatic reaction and should be strictly kept from pH 5 to 7. Advantageously, this pH-value is selected at around 6.5 25 where the reaction is carried out in water and at around 5.5 where the reaction is carried out in a buffer.
On completion of the enzymatic reaction by which the oligomer is formed, the originally clear reaction solution has changed to a milky suspension. The enzyme is then advantageously deactivated, for example by brief heating to 90'C, after which the solid phase forming the 30 required oligomer is separated from the liquid phase. In addition to impurities and secondary reaction products, the reaction medium contains in solution unreacted D- amino acid in the form of its ester (methyl or ethyl ester) where the starting amino acid is in the DL form.
To improve the purity of the oligomers, the solid phase is washed liberally with water.
Separation of the phases may be faciliated by centrifuging.
Purification may also be carried out by dialysis or by ultrafiltration after the solid phase has been re-suspended in water. It is preferred to apply diafiltration, i.e. ultrafiltration with dilution of the retentate. In that case, dilution may be carried out continuously keeping the level constant or even in batches by ultrafiltration without dilution, followed by re-adjustment to the original level before the next ultrafiltration step.
This procedure gives the L-amino acid oligomer of which the characteristics are mentioned above and of which the characterisation means will be indicated in 'the Examples. In the presence of pepsin in acid medium, the oligomer according to the invention is hydrolysed, giving for the most part L-methionine accompanied by di-L-methionine and tri-L-methionine. It is pointed out that, in the case of a homo-oligomer, the oligo-L-methionine may perform the 45 function of L-methionine proper in the fortification of food additives which are poor in methionine.
Under conditions of high acidity, the oligo-L-methionine is cleaved into L-methionine with a negligible degree of racemisation. Preparation of the oligo-L-methionine from DL-methicinine followed by its hydrolysis in acid medium, thus represents an elegant way of preparing L- 50 methionine from its racemic compound.
In a first embodiment of the process according to the invention, a hydrochloride of a methionine ester is dissolved in water in a concentration of preferably from 1 to 2 M. The pH is kept constant at 6.5 throughout the reaction by adding 2N NaOH. Where the methionine used is DL-methionine, its concentration is of course two times higher than where the starting 55 methionine is L-methionine.
The enzyme, mainly papain, romelin or ficin, is added in a quantity of 2% by weight, preferably in two additions of 1 % each. On completion of the reaction, i. e. after about 6 hours, a milky suspension has formed and is briefly heated to 90'C to deactivate the enzyme which it contains. The two phases (solid and liquid) are separated, al-ter which the solid phase-repre- 60 senting the ofigo-L-methionine is washed by diafiltration.
In a second embodiment, the reaction is carried out at a pH-value around 5.5. in a buffer of sodium citrate, succinate or acetate.
The same experimental procedure as described above may be applied in the case of a hetero oligomer by dissolving the various hydrochlorides of the amino acids in question in the 1 a 3 GB2066266A 3 proportions selected in water in the first stage.
The following Examples illustrate the invention and describe the methods used to characterise the oligo-L-methionine. In these Examples, the proportions and percentages quoted represent values by weight.
EXAMPLE 1
Hydrochloride of ethyl ester of L-methionine is conventionally prepared by the action of SOC12 on a solution of L-methionine in ethanol.
The hydrochloride thus formed is then dissolved in water in a quantity of 300 mg per mi (1.4 M). The solution is placed in a pH-stat so as to keep the pH-value constant at 6.5 during the reaction by the addition of 2N NaOH.
A 0. 1 M aqueous solution of papain in L-eysteine is then added in a quantity of 1 % by weight of enzyme. 1 hour later, another 1 % of the enzyme is added in the same way as before.
After a reaction time of 6 hours at 37T at the pH kept strictly constant at 6.5, the originally clear reaction medium has changed into a milky suspension. This suspension is then briefly heated to WC to deactivate the enzyme, followed by separation of the solid phase which is washed liberally with water.
The solid phase thus separated, which represents the crude oligo-Lmethionine, is resuspended in 20 times its weight of water and then introduced into an ultrafiltration cell equipped with an Amicon U M 10 membrane under a nitrogen pressure of 2.5 atms and at a temperature of 4'C (Amicon is a Trade Mark). Ultrafiltration is continued until the volume has been reduced to one twentieth of the initial volume, after which the initial volume is restored by the addition of water and the process is repeated. When about 100 volumes of filtrates have been recovered, ultrafiltration is stopped and the retentate is dried by freeze drying. This retentate represents the purified oligo-L-methionine.
Characterisation of the ofigo-L-methionine 1. The infra-red (I.R.) spectrum in the solid state in a concentration of 1 % in KBr shows the following characteristic bands:
30 3230 cm - 1(s) N-H stretching characteristic of a P structure.
1710 cm - 1(w) C = 0: terminal carboxyl groups 16 20 cm -'(s) C = 0 stretching: amide band 1 1520 cm - 1(s) N = H deformation: amide band 11 700 cm- '(m) vibration outside the plane: amide band V. 35 11. The nuclear magnetic resonance (N.M.R.) spectrum of the proton of the crude oligo-Lmethionine in dimethyl sulphoxide (DMSO-d6) at 80 MHz shows the following characteristic signals:
40 8.2 ppm multiplet (2): terminal amino group H2N 4.4 ppm multiplet (approx. 10 X 2): methylene protons -O-CH,CH, 2.4 ppm multiplet ty [3 and y protons 1.8 ppm shoulder 1 ' 45 2.0 ppm singlet (approx. 10 X 2): thioether protons -S-CH, 1.2 ppm triplet (3): methyl protons -0-CH,-Ch,.
Ill. An elution profile on fine Sephadex G25 resin in dimethyl sulphoxide (DMSO) shows that 50 the oligo-L-methionine is relatively homogeneous, the main peak corresponding ccording to the elution volumes and the working conditions-to the octamer (Sephadex is a Trade Mark).
IV. Other characterisation data are given below:
-insoluble in water and aqueous buffers, -soluble in dimethyl sulphoxide (DMSO), -total nitrogen content between 9.5 and 10. 5%, specific rotation [a]25 12 to - 14, D (DMSO), -circular dichroism 0 = 1922^, two negative bands at 230 and 195 nm, lemental analysis compared with the theorectical (calculated) elemental analyses for the 60 oligomers containing from 6 to 10 methionine residues after cleavage of the ester group by hydrolysis: % C = 45.22; % H = 7.62; % N = 10.58, which corresponds to an average number of residues of 8, _methionine content between 78 and 90%.
4 GB 2 066 266A 4 EXAMPLE 2
The procedure described in Example 1 is repeated using DL-methionine instead of Lmethionine in twice the concentration.
After diafiltration, the same oligo-Lmethionine as in Example 1 is obtained, as shown by the physical properties and the IR and NIVIRspectra.
EXAMPLE 3
The procedure described in Example 1 is repeated using L-methionine, but with ficin instead of papain as the enzyme The oligo-L-methionine obtained is similar to that of Example 1. 10 EXAMPLE 4
The methyl ester of methionine is prepared by the action of SOCI, on a solution of methionine in methanol, and isolated in the form of its hydrochloride.
The procedure described in Example 1 is then repeated using this methyl ester instead of the 15 ethyl ester of that Example in corresponding proportions.
An oligo-L-methionine similar to that of Example 1 is thus obtained.
EXAMPLE 5
The procedure described in Example 1 is modified by using as the reaction medium an 20 aqueous buffer in the form of a 1 M solution of sodium citrate having a pH of 5.5. In this case, the pH remains constant throughout the reaction so that no NaOH has to be added. For the rest, the procedure is as described in Example 1.
An oligo-L-methionine similar to that described in Example 1 is thus obtained.
EXAMPLE 6 The procedure described in Example 2 starting with DLmethionine is repeated using a 1 M sodium acetate buffer of pH 5.5 in accordance with the preceding Example. Once again, the concentration of the IDL-methionine is twice that of the L-methionine on its own. 30 An oligo-L-methionine similar to that described in the preceding Examples is thus obtained. 30 EXAMPLE 7
The oligo-L-methionine described in the preceding Examples is subjected to enzymatic digestion with pepsin from pigs in a quantity of 2% by weight. To this end, the oligo-L- methionine is suspended for 24 hours in a quantity of 2% by weight, at pH 2 and at a temperature of 37'C. Over this period, 85% of the oligo-L- methionine is converted into soluble products. These soluble products consist essentially of free L-methionine (accompanied by traces of the ethyl ester of L-methionine) and of di-L-methionine and tri-L-methionine.
EXAMPLE 8
1 g of the oligo-L-methionine described in Examples 1 to 6 is subjected to acid hydrolysis under nitrogen in approximately 500 mi of 6N hydrochloric acid for about 20 hours at 105 to 11 O'C. The acid is then eliminated by distillation under reduced pressu. e and the hydrolysate is taken up in water. The chromatographically (thin-layer) and electrophoreticaliy pure L-methionine is identified therein along with approximately 1 to 2.5% of D-methionine. The small quantity of 45 D-methionine present may be attributable to the presence of residual D- methionine in the oligomer or to racemisation caused by chemical hydrolysis. The isolated and recrystallised amino acid has a specific rotation [a125 of + 22 to + 23' (6N HQ. By comparison commercial D analytical quality L-methionine has a rotation [a]25 of + 23.7' t 0.5'.
D EXAMPLE 9
Approximately 1 millimole/m] of the hydrochloride of the ethyl ester of IDL-methionine and 0.25 millimole/mi of a,--diethyl glutamate are dissolved in water. The resulting solution is placed in a pH-state at 40-C, the pH being kept at 6.5 by the addition of 2N NaOH. Papain is then added in a quantity of 1 mg/mi. After a reaction time of 6 hours at a constant pH, the 55 enzyme is deactivated and the white precipitate separated by centrifuging is treated by ultrafiltration as described in Example 1. The product is then dispersed in a 0.2N solution of NaOH and, after stirring for 2 hours at ambient temperature, a clear solution is obtained. The pH of the solution is reduced to 10 by the addition of 6N hydrochlorid acid, after which the solution is treated on a column of Sephadex G-1 0 to eliminate the excess salts and to elute the 60 peptides. The neutral solution obtained is concentrated in vacuo and freeze dried. Analysis of the amino acids shows that the product consists of 34 to 35% of glutamic acid for approximately 65% of methionine.
The solubility in water at 2WIC of the hetero-oligomer is 200mg/mf as against 1 the ofigo-L-methionine.
p 1 1 GB2066266A 5 Different solubilities of the oligomer may be obtained by varying the proportions of glutamic acid and methionine in the reaction mixture. For example, where the glutamic acid represents 8.5% of the oligomer, the oligomer has a solubility of 5 to 10 mg/mi.
EXAMPLES 10 to 11 One millimole/mi of the hydrochloride of the ethyl ester of DL-methionine and 0.25 millimote/mi of the hydrochloride of the ethyl ester of DL- tryptophan are subjected to the enzymatic treatment described in Example 1, giving a white water-insoluble powder containing -according to analysis of the amino acids-1 1 - : 3.5% of L-trytophan (Example 10).
The same procedure as described above using 0.25 millimole/mi of the hydrochloride of the 10 ethyl ester of L-tyrosine instead of that of DL-tryptophan gives a hetero- oligomer containing 14 L 2% of L-tyrosine (Example 11).
The addition of tryptophan or tyrosine to the reaction medium facilitates enzymatic digestion of the ofigomer by the pancreatic proteases, as shown in the following:
A 5% dispersion of the oligomers in water is subjected to digestion by 5 mg/mi of pancreatin 15 in a pH-stat at pH 8 and at a temperature aof 4WC. At different times, samples are subjected to the reaction with ninhydrin to determine their content of nitrogen in the a-position in the soluble fraction. The results are shown in the following Table:
% nitrogen in the a-position after digestion for Example
No. Oligomer 1 h 6 h 20 h 1 methionine 9 24 39 methionine/ tryptophan 29 49 79 11 methionine/ tyrosine 25 46 56 30

Claims (17)

1. An enzymaticaliy obtained oligomer of L-amino acid containing residues of L-methionine, consisting essentially of oligomers having a chain length of from 5 to 10 residues with an 35 average length of 8 and having an L-methionine content amounting to form 60 to 90% by weight.
2. An oligomer as claimed in Claim 1, consisting of residues of Lmethionine, which is iriso!uble in water and aqueous buffers and soluble in dimethyl sulphoxide (DMSO), having a total nitrogen content amounting to from 9.5 to 10.5% by weight and having a specific rotation 40 [a]25 of from - 12 to - 14' (DMSO).
D
3. An oligomer as claimed in Claim 1, aromatic amino acids.
4. An afigomer as claimed in Claim 3, wherein the polar amino acids are glutamic acid or aspartic acid, and the aromatic amino acids are tryptophan, phenyl alanine or tyrosine.
5. An enzymatically obtained oligomer of L-amino acid substantially as described with particular reference to any of the Examples.
6. A process for preparing an oligomer of L-amino acid as claimed in any of Claims 1 to 5, which comprises reacting an ester of methionine and, optionally, of one or more other amino acids, with a thiol-protease in an aqueous medium having a pH-value in the range from 5 to 7 50 at a temperature where the thiol-protease is active, and thereafter isolating the L-amino acid oligomer formed from the reaction medium.
7. A process as claimed in Claim 6, wherein the thioi-protease is deactivated before isolation of the L-amino acid oligomer.
8. A process as claimed in Claim 6 or 7, wherein the methionine is Lmethionine or DL- 55 methionine.
9. A process as claimed in any of Claims 6 to 8, wherein the other amino acid(s) is/are glutamic acid, L-tryptophane, DL-tryptophan or DL-tyrosine.
10. A process as claimed in any of Claims 6 to 9, wherein the ester of methionine and the cither amino acid(s) is the methyl or ethyl ester.
11. A process as claimed in any of Claims 6 to 10, wherein the thiolprotease is papain, ficin or bromelin and the aqueous reaction medium is kept at a pH of from 5 to 7 by means of a phi-stat or is a buffer solution of a sodium salt of a carboxylic acid.
12. A process as claimed in any of Claims 6 to 11, wherein the L-amino acid oligomer is isolated by ultrafiltration with dilution of the retentate during the ultrafiltration process.
which contains residues of polar amino acids or 6 GB2066266A 6
13. A process for preparing an oligomer of L-amino acid substantially as described with particular reference to any of the Examples.
14. An oligomer of L-amino acid when prepared by a process as claimed in any of Claims 6 to 12,
15. A food poor in methionine having added thereto an oligomer of L-amino acid as claimed 5 in any of Claims 1 to 5 or 14 to enhance its nutritive value.
16. A process for the production of L-methionine which comprises hydrolysing in acid medium an oligomer of L-amino acid as claimed in any of Claims 1 to 5 or 14 and prepared from DL-methionine.
17. L-methionine when prepared by a process as claimed in Claim 16.
Printed for Her Majesty S Station-r Office by Burgess Er Son (Abingdon) Ltd -198 1 Published at The Patnt Office 25 Southampton Buildings London WC2A 'I AY from which copies may be obtained R j A
GB8041099A 1979-12-28 1980-12-22 Enzymatically obtained oligomer of lamino acid a process for its preparation and its uses Expired GB2066266B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH11505/79A CH647550A5 (en) 1979-12-28 1979-12-28 PROCESS FOR THE PREPARATION OF AN OLIGO-L-METHIONINE BY THE ENZYMATIC ROUTE AND THE USE THEREOF.

Publications (2)

Publication Number Publication Date
GB2066266A true GB2066266A (en) 1981-07-08
GB2066266B GB2066266B (en) 1983-11-30

Family

ID=4374130

Family Applications (1)

Application Number Title Priority Date Filing Date
GB8041099A Expired GB2066266B (en) 1979-12-28 1980-12-22 Enzymatically obtained oligomer of lamino acid a process for its preparation and its uses

Country Status (10)

Country Link
EP (1) EP0031527B1 (en)
JP (2) JPS56103201A (en)
AU (1) AU540614B2 (en)
CH (1) CH647550A5 (en)
DE (1) DE3067591D1 (en)
ES (1) ES498130A0 (en)
GB (1) GB2066266B (en)
HK (1) HK49885A (en)
MY (1) MY8500515A (en)
SG (1) SG20384G (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987006268A1 (en) * 1986-04-10 1987-10-22 Commonwealth Scientific And Industrial Research Or Enzymatic synthesis
WO2002088667A2 (en) * 2001-05-02 2002-11-07 Novus International, Inc. ENANTIOSELECTIVE OLIGOMERIZATION OF α-HYDROXY CARBOXYLIC ACIDS AND α-AMINO ACIDS
US6939693B2 (en) 1999-10-29 2005-09-06 Novus International, Inc. Enantioselective oligomerization of α-hydroxy carboxylic acids and α-amino acids

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2584077B1 (en) * 1985-06-28 1988-07-08 Irceba L-DI OR TRIPEPTIDES HAVING BIOLOGICAL ACTIVITY FOR USE IN HUMAN AND VETERINARY MEDICINE, PROCESS FOR OBTAINING THEM AND MEDICINAL CONTAINING THE SAME
CA2389233A1 (en) 1999-10-29 2001-05-10 Paul K. S. Nam Oligomers and oligomeric segments of alpha-hydroxy carboxylic acids and alpha-amino acids

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1263336A (en) * 1968-02-14 1972-02-09 Morton Norwich Products Inc Food composition
CH589047A5 (en) * 1972-10-23 1977-06-30 Degussa
US4086136A (en) * 1975-10-23 1978-04-25 (Zaidanhojin) Sagami Chemical Research Center Process for producing a peptide using a serine or thiol proteinase
DE2909854A1 (en) * 1978-03-23 1979-10-04 Miles Lab L-Aminoacid-substd. polypeptide food additive prepn. - by reacting protein, aminoacid alkyl ester hydrochloride and proteolytic enzyme

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987006268A1 (en) * 1986-04-10 1987-10-22 Commonwealth Scientific And Industrial Research Or Enzymatic synthesis
US6939693B2 (en) 1999-10-29 2005-09-06 Novus International, Inc. Enantioselective oligomerization of α-hydroxy carboxylic acids and α-amino acids
WO2002088667A2 (en) * 2001-05-02 2002-11-07 Novus International, Inc. ENANTIOSELECTIVE OLIGOMERIZATION OF α-HYDROXY CARBOXYLIC ACIDS AND α-AMINO ACIDS
WO2002088667A3 (en) * 2001-05-02 2003-07-03 Novus Int Inc ENANTIOSELECTIVE OLIGOMERIZATION OF α-HYDROXY CARBOXYLIC ACIDS AND α-AMINO ACIDS

Also Published As

Publication number Publication date
EP0031527A2 (en) 1981-07-08
ES8201207A1 (en) 1981-12-01
JPS6246559B2 (en) 1987-10-02
DE3067591D1 (en) 1984-05-24
AU6545480A (en) 1981-07-23
ES498130A0 (en) 1981-12-01
AU540614B2 (en) 1984-11-29
GB2066266B (en) 1983-11-30
JPS645021B2 (en) 1989-01-27
HK49885A (en) 1985-07-05
MY8500515A (en) 1985-12-31
EP0031527B1 (en) 1984-04-18
JPS62252760A (en) 1987-11-04
CH647550A5 (en) 1985-01-31
SG20384G (en) 1985-01-04
EP0031527A3 (en) 1981-07-22
JPS56103201A (en) 1981-08-18

Similar Documents

Publication Publication Date Title
Ahmad et al. Recent advances on the role of process variables affecting gelatin yield and characteristics with special reference to enzymatic extraction: A review
JP3153237B2 (en) Protein hydrolyzate
US4452888A (en) Process for producing a low-molecular weight peptide composition and nutrient agent containing the same
US8092987B2 (en) Mucosa tissue preserved with heating and hydrogen peroxide or phosphoric acid
JP2001506858A (en) Method for producing protein hydrolyzate
JPS5815120B2 (en) Seibutsugakutekikasuibunkaiyoru Yukisanrui no Seizouhou
JPH0154985B2 (en)
GB2066266A (en) An enzymatically obtained oligomer of L-amino acid, a process for its preparation and its uses
US4235942A (en) Digestible polyamino acids
US5021338A (en) Enzyme extract from germinated sorghum for hydrolysis of protein material
JP2958801B2 (en) Method for producing debittered functional peptide
US4871575A (en) Flavor and texture improved canned animal flesh and process
JP4334698B2 (en) Protein enzyme degradation product
JP2737790B2 (en) Food containing silk protein hydrolyzate and method for producing the same
JP2799352B2 (en) Process for producing corn gluten meal hydrolyzate
YASUMOTO et al. Aspartyl-and glutamyl-lysine crosslinks formation and their nutritional availability
US4495206A (en) High protein, solid dietary food product
Ferjancic et al. Papain-catalyzed polymerization of amino acids in low water organic solvents
Ferjancic‐Biagini et al. Acylation of food proteins and hydrolysis by digestive enzymes: A review
JPH1175887A (en) Conversion of protein into cross-linked polymer with peroxidase
Gaertner et al. Covalent attachment of poly (L-methionine) to food proteins for nutritional and functional improvement
NL8100280A (en) PROCESS FOR DEGRADING PROTEINS WITH PROTEINASES.
JPS6314681A (en) Production of enzymic hydrolyzate of egg white
JPS58175447A (en) Proteinic nutritious material without unpleasant taste
KR100475833B1 (en) High yield peptide preparation method

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 19971222